As the world divides more dramatically between the very rich and the very poor with fewer and fewer people in between, certain companies are thriving.\u00a0 Manufacturing for the rich is still highly profitable.\u00a0 This hit home when the CEO of Bayer said recently that Bayer\u2019s new anti-cancer drug would cost $69,000 a year, over forty times the annual income of an Indian.\u00a0 Of course, remarked CEO Marjin Dekkers, this new drug was not developed for poor people.<\/p>\n
In the US with attrition high in the middle class, manufacturers have given up making products that appeal to the average family, and are now pitching mostly to the upper end of the income scale.<\/p>\n
How many companies will fail as they manufacture out of their comfort zone?\u00a0 Can any healthy economy survive without a middle class?\u00a0 Conventional wisdom says that the rich can only spend so much of their money and the poor can\u2019t spend at all.\u00a0 Without the middle, the flow of goods and services becomes sluggish as best.<\/p>\n
As the world divides more dramatically between the very rich and the very poor with fewer and fewer people in between, certain companies are thriving.\u00a0 Manufacturing for the rich is still highly profitable.\u00a0 This hit home when the CEO of … Continue reading ![\"Drugs](\"http:\/\/www.w-t-w.org\/en\/wp-content\/uploads\/2014\/02\/Drugs-for-the-Rich-Only-300x213.jpg\")
<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"